Here are three details:
1. Because of the technology, patients have walked 50,000 miles in the EksoGT exoskeleton to date.
2. The technology is designed to help patients get back on their feet. Along with the company’s SmartAssist software, the exoskeleton supports re-learning correct step partners, weight shifting and mitigating compensatory behaviors.
3. The FDA cleared EksoGT for use with stroke and spinal cord injuries from L5 to C7.
More articles on devices and implants:
Medtronic nabs No. 43 on Management Top 250 list
Spineology welcomes 2 new board members
Nexxt Spine launches posterior cervical thoracic system: 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
